Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02766: Variant p.Glu109Lys

Transthyretin
Gene: TTR
Feedback?
Variant information Variant position: help 109 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 109 (E109K, p.Glu109Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AMYLD1; amyloid polyneuropathy. Any additional useful information about the variant.


Sequence information Variant position: help 109 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 147 The length of the canonical sequence.
Location on the sequence: help YKVEIDTKSYWKALGISPFH E HAEVVFTANDSGPRRYTIAA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         YKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAA

Chimpanzee                    YKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAA

Mouse                         YRVELDTKSYWKTLGISPFHEFADVVFTANDSGHRHYTIAA

Rat                           YRVELDTKSYWKALGISPFHEYAEVVFTANDSGHRHYTIAA

Pig                           YKVELDTKSYWKALGISPFHEYAEVVFTANDSGRRHYTIAA

Bovine                        YKVELDTKSYWKSLGISPFHEFAEVVFTANDSGPRHYTIAA

Rabbit                        YKVELDTKSYWKALGISPFHEYAEVVFTANDSGHRSYTIAA

Sheep                         YKVELDTKSYWKSLGISPFHEYAEVVFTANDSGLRHYTIAA

Chicken                       YRVEFDTSSYWKGLGLSPFHEYADVVFTANDSGHRHYTIAA

Xenopus laevis                YKIEFATKAFWGKLGLSPFHEYVDVVFTANDAGHRHYTIAV

Xenopus tropicalis            YKIEFATKTFWRKLGLSPFHEYVDVVFSANDAGHRHYTIAV
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 21 – 147 Transthyretin
Glycosylation 118 – 118 N-linked (GlcNAc...) asparagine
Mutagenesis 107 – 107 F -> M. Loss of tetramerization; when associated with M-130.
Beta strand 107 – 118



Literature citations
A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy.
Nakamura M.; Hamidi Asl K.; Benson M.D.;
Amyloid 7:46-50(2000)
Cited for: VARIANT AMYLD1 LYS-109;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.